Reports

Ideas That Generate Results

1. Analyst View
 
2. Research Methodology

3. Molecular Diagnostics - An Introduction

4. Market Dynamics
    4.1 Drivers
          4.1.1 Rising Incidence of Cancer and Infectious Diseases
          4.1.2 Benefits of Molecular Diagnostic Tests Over Traditional Methods
          4.1.3 Increasing Awareness of Personalized Medicine, Biomarkers,& Companion Diagnostics
          4.1.4 Technological Advancements
          4.1.5 Improving Reimbursement Scenario
    4.2 Restraints
          4.2.1 High Costs of Molecular Diagnostics Tests
          4.2.2 Regulatory Issues Related to Molecular Diagnostics Tests
    4.3 Trends
           4.3.1 Upsurge in the Number of Strategic Alliances
           4.3.2 Automation & Multiplexing: A Growing Trend
    4.4 Opportunities
          4.4.1 Significant Growth Opportunities in Emerging Markets
          4.4.2 Genetic Testing: A New Revenue Pocket for Molecular Diagnostics Market

5. Molecular Diagnostics Market Overview
    5.1 Current Market Size and Future Growth

6. Molecular Diagnostics Market, By Application
    6.1 Introduction
          6.1.1 Infectious Diseases
          6.1.2 Oncology
          6.1.3 Blood Screening
          6.1.4 Genetic Testing

7. Molecular Diagnostics Market, By Technology
    7.1 Introduction
          7.1.1 Polymerase Chain Reaction (PCR)
          7.1.2 Nucleic Acid Hybridization
          7.1.3 DNA Sequencing and Next Generation Sequencing (NGS)

8. Molecular Diagnostic Market, By Region
    8.1 Introduction
          8.1.1 North America
          8.1.2 Europe
          8.1.3 Asia Pacific

9. Key Player Analysis
    9.1 Abbott Diagnostics (A Division of Abbott Laboratories)
    9.2 Alere Inc.
    9.3 Becton, Dickinson and Company
    9.4 bioMérieux SA
    9.5 Cepheid
    9.6 Danaher Corporation
    9.7 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
    9.8 Hologic, Inc.
    9.9 QIAGEN N.V.
    9.10 Siemens Healthcare
    9.11 Thermo Fisher Scientific Inc.